Federation des caisses Desjardins du Quebec’s Virtus Biotech ETF BBP Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,000	Closed	-$87.7K	–	2138
2018 Q2	$87.7K	Hold	2,000	–	–	﹤0.01%	1217
2018 Q1	$82.5K	Hold	2,000	–	–	﹤0.01%	1212
2017 Q4	$81.1K	Sell	2,000 -225	-10%	-$8.98K	﹤0.01%	1217
2017 Q3	$92.5K	Sell	2,225 -300	-12%	-$12K	﹤0.01%	1169
2017 Q2	$100K	Sell	2,525 -1,225	-33%	-$45.7K	﹤0.01%	1222
2017 Q1	$142K	Buy	+3,750	New	+$137K	﹤0.01%	967

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SMG

Smart Money Group Eastland, Texas $344M AUM 16.66% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

FAIM

Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BBP Position: Q3 2018 in Review

Federation des caisses Desjardins du Quebec sold out of Virtus Biotech ETF (BBP) in Q3 2018, closing a stake of 2,000 shares — an estimated $87.7K sold.

Federation des caisses Desjardins du Quebec first reported a position in BBP in Q1 2017 and held it in 6 quarters. The position peaked at $142K in Q1 2017. 17 funds tracked by Wall St. Rank hold BBP as of Q3 2018.

Federation des caisses Desjardins du Quebec reported no remaining Virtus Biotech ETF position as of Q3 2018 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 2,000 Virtus Biotech ETF shares in Q3 2018, an estimated $87.7K.
Federation des caisses Desjardins du Quebec first reported a position in Virtus Biotech ETF in Q1 2017 and held it in 6 quarters.
Federation des caisses Desjardins du Quebec's Virtus Biotech ETF position peaked at $142K in Q1 2017.
17 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2018.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2018, filed 30 Aug 2024.